Antibody prophylaxes mogelijk maken voor ouderen en kwetsbaren, gebruik makend van gistgebaseerde biotechnologie.
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils
Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering
Generation of single domain antibody fragments derived from camelids and generation of manifold constructs